in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Avantor signs development agreement with Rubicon Research for pharma excipients
12:46 PM MDT | October 16, 2012 | Lindsay Frost
Avantor Performance Materials (Center Valley, PA) has signed a collaboration agreement with Rubicon Research (Mumbai) to develop, manufacture, and market products for the functional excipient market in pharmaceuticals. The companies plan to develop a novel gastroretentive excipient that can enable molecule delivery with a window of absorption, allowing targeted delivery and a therapeutic advantage with more options for the pharmaceutical excipient segment. “The Rubicon team is excited to work with Avantor in introducing this novel polymeric material as a...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee